TW200509996A - Tablet containing 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethylester or the salts thereof - Google Patents
Tablet containing 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethylester or the salts thereofInfo
- Publication number
- TW200509996A TW200509996A TW093124426A TW93124426A TW200509996A TW 200509996 A TW200509996 A TW 200509996A TW 093124426 A TW093124426 A TW 093124426A TW 93124426 A TW93124426 A TW 93124426A TW 200509996 A TW200509996 A TW 200509996A
- Authority
- TW
- Taiwan
- Prior art keywords
- methyl
- amino
- hexyloxycarbonylamino
- benzimidazole
- imino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10337697A DE10337697A1 (de) | 2003-08-16 | 2003-08-16 | Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200509996A true TW200509996A (en) | 2005-03-16 |
Family
ID=34201585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW093124426A TW200509996A (en) | 2003-08-16 | 2004-08-13 | Tablet containing 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethylester or the salts thereof |
Country Status (17)
Country | Link |
---|---|
US (1) | US20050038077A1 (zh) |
EP (1) | EP1658056B1 (zh) |
JP (1) | JP4977462B2 (zh) |
AR (1) | AR045732A1 (zh) |
AT (1) | ATE394094T1 (zh) |
CA (1) | CA2535810C (zh) |
CY (1) | CY1108218T1 (zh) |
DE (2) | DE10337697A1 (zh) |
DK (1) | DK1658056T3 (zh) |
ES (1) | ES2307041T3 (zh) |
PE (1) | PE20050342A1 (zh) |
PL (1) | PL1658056T3 (zh) |
PT (1) | PT1658056E (zh) |
SI (1) | SI1658056T1 (zh) |
TW (1) | TW200509996A (zh) |
UY (1) | UY28468A1 (zh) |
WO (1) | WO2005018615A1 (zh) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030181488A1 (en) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
DE10339862A1 (de) * | 2003-08-29 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel |
DE102005020002A1 (de) * | 2005-04-27 | 2006-11-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Physiologisch verträgliche Salze von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester |
KR20090029849A (ko) * | 2006-07-17 | 2009-03-23 | 베링거 인겔하임 인터내셔날 게엠베하 | 심장혈관 분야에서 직접 트롬빈 억제제에 대한 새로운 징후 |
AU2009228795B2 (en) * | 2008-03-28 | 2014-02-13 | Boehringer Ingelheim International Gmbh | Process for preparing orally administered dabigatran formulations |
CN102099012A (zh) * | 2008-07-14 | 2011-06-15 | 贝林格尔.英格海姆国际有限公司 | 制备含有达比加群的药物制剂的方法 |
PE20141585A1 (es) | 2008-07-28 | 2014-11-13 | Takeda Pharmaceutical | Composicion farmaceutica estabilizada a base de un compuesto no petidico |
HUP1000069A2 (en) * | 2010-02-02 | 2012-05-02 | Egis Gyogyszergyar Nyilvanosan M Kod Ruszvunytarsasag | New salts for the preparation of pharmaceutical composition |
CA2792273A1 (en) | 2010-03-08 | 2011-09-15 | Ratiopharm Gmbh | Dabigatran etexilate-containing pharmaceutical composition |
EA022969B1 (ru) | 2010-07-01 | 2016-03-31 | Крка, Товарна Здравил, Д.Д., Ново Место | Пероральные фармацевтические лекарственные формы, содержащие дабигатрана этексилат и его фармацевтически приемлемые соли |
US20140294959A1 (en) | 2011-05-20 | 2014-10-02 | Astrazeneca Uk Limited | Pharmaceutical Composition of Rosuvastatin Calcium |
EA201391758A1 (ru) | 2011-05-24 | 2014-06-30 | Тева Фармасьютикал Индастриз Лтд. | Спрессованная сердцевина для фармацевтической композиции, содержащая органические кислоты |
CN102391250B (zh) * | 2011-08-29 | 2013-06-19 | 石药集团欧意药业有限公司 | 一种达比加群酯化合物、制备方法及其药物组合物 |
HUE056194T2 (hu) | 2012-02-21 | 2022-01-28 | Towa Pharmaceutical Europe S L | Dabigatrán-etexilát orális gyógyszerészeti készítményei |
US20130345262A1 (en) | 2012-06-25 | 2013-12-26 | Boehringer Ingelheim International Gmbh | Method for prevention of stroke |
BR112015005489B1 (pt) * | 2012-09-19 | 2022-07-12 | Taiho Pharmaceutical Co., Ltd. | Composição farmacêutica para administração oral com dissolução e/ou absorção aperfeiçoadas |
EP2722033A1 (en) * | 2012-10-19 | 2014-04-23 | Sanovel Ilac Sanayi ve Ticaret A.S. | Pharmaceutical Compositions of Dabigatran Free Base |
WO2014060561A1 (en) * | 2012-10-19 | 2014-04-24 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Oral pharmaceutical formulations comprising dabigatran |
CN103230378B (zh) * | 2013-05-10 | 2014-12-10 | 青岛双鲸药业有限公司 | 一种氯雷他定片的制备方法 |
EP2853260A1 (en) * | 2013-09-27 | 2015-04-01 | ratiopharm GmbH | Pharmaceutical preparation comprising dabigatran etexilate bismesylate |
CN104784147B (zh) * | 2014-01-20 | 2018-01-23 | 成都苑东生物制药股份有限公司 | 一种甲磺酸达比加群酯胶囊药物组合物及其制备方法 |
IN2014MU01042A (zh) | 2014-03-26 | 2015-10-02 | Cadila Healthcare Ltd | |
EP4205743A1 (en) | 2014-12-31 | 2023-07-05 | Shenzhen Pharmacin Co., Ltd. | Pharmaceutical composition and preparation method therefor |
WO2017103945A1 (en) * | 2015-12-15 | 2017-06-22 | Strides Shasun Limited | Pharmaceutical compositions |
WO2017111637A1 (en) | 2015-12-23 | 2017-06-29 | Zaklady Farmaceutyczne Polpharma Sa | Pharmaceutical composition comprising dabigatran or a pharmaceutically acceptable salt thereof |
EP3332771A1 (en) | 2016-12-07 | 2018-06-13 | Sanovel Ilac Sanayi ve Ticaret A.S. | Multilayered tablet compositions of dabigatran |
JP2018104425A (ja) * | 2016-12-26 | 2018-07-05 | 日本ケミファ株式会社 | ダビガトランエテキシラートまたはその薬学的に許容される塩を含有する錠剤 |
JP2018184375A (ja) * | 2017-04-27 | 2018-11-22 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ダビガトランエテキシラート又は医薬的に許容されるその塩を含む錠剤及びその製造方法 |
TR201706848A2 (tr) | 2017-05-10 | 2018-11-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Dabigatran eteksi̇lat i̇çeren kati oral farmasöti̇k kompozi̇syonlar |
WO2019004980A2 (en) | 2017-05-10 | 2019-01-03 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF DABIGATRAN DEXILATE |
TR201722323A2 (tr) | 2017-12-27 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Dabi̇gatranin oral farmasöti̇k kompozi̇syonlari |
TR201722186A2 (tr) | 2017-12-27 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Dabi̇gatranin farmasöti̇k kompozi̇syonlari |
TR201722630A2 (zh) | 2017-12-28 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3126703A1 (de) * | 1981-07-07 | 1983-01-27 | Dr. Karl Thomae Gmbh, 7950 Biberach | Bromhexin-retardform und verfahren zu ihrer herstellung |
KR880002139B1 (ko) * | 1983-04-08 | 1988-10-17 | 베링거 인겔하임 리미티드 | 경구 투여용 정제의 제조방법 |
US4921707A (en) * | 1986-06-24 | 1990-05-01 | Istvan Racz | Proceeding for the production of pharmaceutical preparations of high gastric acid binding capacity, of retarded effect and of increased bioavailability |
FR2745500B1 (fr) * | 1996-03-04 | 1998-04-03 | Synthelabo | Formulations pharmaceutiques a liberation prolongee contenant de la mizolastine |
PE121699A1 (es) * | 1997-02-18 | 1999-12-08 | Boehringer Ingelheim Pharma | Heterociclos biciclicos disustituidos como inhibidores de la trombina |
DE10133786A1 (de) * | 2001-07-16 | 2003-02-06 | Boehringer Ingelheim Pharma | Verwendung von Thrombin-Inhibitoren zur Behandlung von Arthritis |
US20030181488A1 (en) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
PT1485094E (pt) * | 2002-03-07 | 2012-10-09 | Boehringer Ingelheim Int | Forma de administração por via oral para 3-[(2-{[4- (hexiloxicarbonilamino-imino-metil)-fenilamino]-metil}-1-metil- 1h-benzimidazole-5-carbonil)-piridin-2-il-amino]-propionato de etilo ou os seus sais |
DE10339862A1 (de) * | 2003-08-29 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel |
-
2003
- 2003-08-16 DE DE10337697A patent/DE10337697A1/de not_active Withdrawn
-
2004
- 2004-07-29 US US10/901,809 patent/US20050038077A1/en not_active Abandoned
- 2004-08-10 SI SI200430739T patent/SI1658056T1/sl unknown
- 2004-08-10 DK DK04763952T patent/DK1658056T3/da active
- 2004-08-10 AT AT04763952T patent/ATE394094T1/de active
- 2004-08-10 JP JP2006523572A patent/JP4977462B2/ja not_active Expired - Lifetime
- 2004-08-10 DE DE502004007069T patent/DE502004007069D1/de not_active Expired - Lifetime
- 2004-08-10 PL PL04763952T patent/PL1658056T3/pl unknown
- 2004-08-10 PT PT04763952T patent/PT1658056E/pt unknown
- 2004-08-10 ES ES04763952T patent/ES2307041T3/es not_active Expired - Lifetime
- 2004-08-10 EP EP04763952A patent/EP1658056B1/de not_active Expired - Lifetime
- 2004-08-10 CA CA2535810A patent/CA2535810C/en not_active Expired - Fee Related
- 2004-08-10 WO PCT/EP2004/008934 patent/WO2005018615A1/de active IP Right Grant
- 2004-08-13 PE PE2004000786A patent/PE20050342A1/es not_active Application Discontinuation
- 2004-08-13 TW TW093124426A patent/TW200509996A/zh unknown
- 2004-08-13 UY UY28468A patent/UY28468A1/es not_active Application Discontinuation
- 2004-08-13 AR ARP040102904A patent/AR045732A1/es unknown
-
2008
- 2008-07-28 CY CY20081100781T patent/CY1108218T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2005018615A1 (de) | 2005-03-03 |
CA2535810C (en) | 2013-06-25 |
UY28468A1 (es) | 2005-03-31 |
DE10337697A1 (de) | 2005-03-24 |
PE20050342A1 (es) | 2005-06-17 |
ES2307041T3 (es) | 2008-11-16 |
PT1658056E (pt) | 2008-06-23 |
US20050038077A1 (en) | 2005-02-17 |
ATE394094T1 (de) | 2008-05-15 |
AR045732A1 (es) | 2005-11-09 |
DK1658056T3 (da) | 2008-09-08 |
EP1658056A1 (de) | 2006-05-24 |
DE502004007069D1 (en) | 2008-06-19 |
SI1658056T1 (sl) | 2008-08-31 |
CY1108218T1 (el) | 2014-02-12 |
CA2535810A1 (en) | 2005-03-03 |
JP4977462B2 (ja) | 2012-07-18 |
EP1658056B1 (de) | 2008-05-07 |
JP2007502788A (ja) | 2007-02-15 |
PL1658056T3 (pl) | 2008-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200509996A (en) | Tablet containing 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethylester or the salts thereof | |
MY145696A (en) | 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-menthyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethylester-methanesulfonate and its use as a medicament | |
TW200716610A (en) | Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester | |
UA96314C2 (ru) | Замещенные 1-(3-пиридинил)пиразол-4-илуксусные кислоты и их применение в качестве гербицидов и регуляторов роста растений | |
BR0306559A (pt) | Forma de aplicação oral para etilésteres de ácido 3-[(2-{[4-(hexiloxicarbonilamino-imino-metil)-fenilamin o]-metil}-1-metil-1h-ben-zimidazol-5-carbonil)-piridin- 2-il-amino]-propiÈnico e seus sais | |
NZ599343A (en) | Substituted piperidines that increase p53 activity and the uses thereof | |
UA81567C2 (en) | Heteroaroyl-substituted phenylalanine amides | |
TW200745028A (en) | Novel sulphonylpyrroles | |
UA88477C2 (ru) | Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение | |
UA99908C2 (ru) | Пиридопиразиновые производные, способ борьбы с растениями, гербицидные композиции | |
MX2007006474A (es) | Procedimiento para combatir enfermedades fungicas en leguminosas. | |
IL185275A0 (en) | N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same | |
UA100501C2 (uk) | Карбоксамідні сполуки і їх застосування як інгібіторів кальпаїнів | |
NZ594597A (en) | Substituted piperidines as ccr3 antagonists | |
MX2007000392A (es) | Derivados de 2-pirrolidona sustituida como fungicidas e insecticidas. | |
UA86172C2 (ru) | Пестицидная композиция, применение композиции для борьбы с вредителями и для защиты семян, способы защиты растений и борьбы с вредителями | |
MY145936A (en) | Solid state forms of racemic ilaprazole | |
NO20063268L (no) | Fremgangsmate til fremstilling av 1-(2S,3S)-2-benzhydryl-N-(5-tert-butyl-2-metoksybenzyl)quinuklidin-3-amin | |
GEP20084361B (en) | Piperidinylcarbonyl-pyrro-lidines and their use as melanocortin agonists | |
UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
MX2009006177A (es) | Composiciones de acetaminofen que tienen efectos colaterales minimizados incluyendo lepatotoxicidad reducida. | |
WO2008047951A3 (en) | An alzheimer' s disease progression inhibitor containing heterocyclic compound | |
TW200720273A (en) | Pharmaceutically active spiro-benzimidazoles | |
UA95601C2 (ru) | Метансульфонат этилового эфира 3-[(2-{[4-(гексилоксикарбониламиноиминометил)фениламино]метил}-1метил-1н- бензимидазол-5-карбонил)пиридин-2-иламино]пропионовой кислоты и фармацевтическая композиция, которая его содержит | |
HK1087638A1 (en) | Use of tyrosine kinase inhibitors to treat diabetes |